Innovation
2 patent families — focus: Human necessities; filing pace active. Cited 8 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 1.3K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record; lead investors include Mid America Angels, Kansas Bioscience Authority, InvestMidwest.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 1 | 25% |
| Angel & family office | 1 | 25% |
| Other / undisclosed | 1 | 25% |
Recent activity
20 Mar 2026
Event
VCS/VSSO presentation on survival data from ASCENT study
2 Mar 2026
Event
AHNTI
23 Feb 2026
Partnership
ECI® Authorized Treatment Center